News
1d
Zacks Investment Research on MSNMerck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook CutMerck MRK reported first-quarter 2025 adjusted earnings per share (EPS) of $2.22, which beat the Zacks Consensus Estimate of ...
UPPSALA, SE / ACCESS Newswire / April 23, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured an ...
Though it is commonly given as an i.v. bolus, it can be used as a continuous infusion [12] by adjusting the dose to the degree of neuromuscular blockade that is desired (Table 1). Pancuronium is ...
In mechanically ventilated patients with ARDS, the treatment effect of neuromuscular blockade on mortality likely varies with respiratory elastance.
Non-coding RNAs as modifiers of neuromuscular disease-The Alexander lab is especially ... Additionally, we demonstrated that miR-486 overexpression in dystrophic mouse muscles can block the ...
The decision to treat a patient in the intensive care unit (ICU) with neuromuscular blocking agents (NMBAs) (for reasons other than the placement of an endotracheal tube) is a difficult one that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results